Indacaterol/glycopyrronium bromide fixed-dose combination for the treatment of copd

Keyphrases

• Chronic Obstructive Pulmonary Disease 100%
• Fixed-dose Combination 100%
• Copd 100%
• Indacaterol/glycopyrronium 100%
• Glycopyrronium Bromide 100%
• Bronchodilator Therapy 66%
• Adrenoceptor Agonist 66%
• Pharmacological Therapy 33%
• Combination Therapy 33%
• Premature Mortality 33%
• Maintenance Therapy 33%
• Morbidity Mortality 33%
• Additive Effect 33%
• Rescue Medication 33%
• Once-daily Regimen 33%
• Antimuscarinics 33%
• Ultra-long 33%
• Enhanced Efficacy 33%
• Inhalational 33%
• Long-acting Agents 33%
• Pharmacologic Management 33%
• Long-acting Antimuscarinic Agents 33%
• Indacaterol Maleate 33%
• Combination Inhalers 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Obstructive Lung Disease 100%
• Glycopyrronium 100%
• Indacaterol 100%
• Adrenergic Receptor Stimulating Agent 66%
• Bronchodilating Agent 66%
• Muscarinic Receptor Blocking Agent 66%
• Symptom 33%
• Combination Therapy 33%
• Premature Mortality 33%
• Long Acting Drug 33%